TALPHERA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
TALPHERA, INC. (TLPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 60.05 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-12
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 3.00K shares, a 80.00% decline year-over-year.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 57.05K shares, a 613.16% increase year-over-year.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 3.73K shares, a 95.98% decline year-over-year.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 22.92K shares, a 63.63% increase year-over-year.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 49.64K shares, a 58.24% decline from fiscal 2024.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 118.88K shares, a 11.56% increase from fiscal 2023.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 106.56K shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 801.75K shares, a 23.04% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 60.05K shares 10-Q · filed 2026-08-12 | 63.78K shares derived: sum of 3 quarters · filed 2026-08-12 | 86.70K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 57.05K shares 10-Q · filed 2026-05-13 | 60.78K shares derived: sum of 2 quarters · filed 2026-05-13 | 83.70K shares derived: sum of 3 quarters · filed 2026-05-13 | 98.70K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 3.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 26.64K shares derived: sum of 2 quarters · filed 2026-03-23 | 41.64K shares derived: sum of 3 quarters · filed 2026-03-23 | 49.64K shares 10-K · filed 2026-03-23 |
| 2025-09-30 | 22.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 37.92K shares derived: sum of 2 quarters · filed 2025-11-12 | 45.92K shares 10-Q · filed 2025-11-12 | 138.47K shares derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | 15.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 23.00K shares 10-Q · filed 2025-08-14 | 115.55K shares derived: sum of 3 quarters · filed 2026-03-23 | 129.56K shares derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | 8.00K shares 10-Q · filed 2025-05-14 | 100.55K shares derived: sum of 2 quarters · filed 2026-03-23 | 114.56K shares derived: sum of 3 quarters · filed 2026-03-23 | 114.56K shares derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | 92.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 106.56K shares derived: sum of 2 quarters · filed 2026-03-23 | 106.56K shares derived: sum of 3 quarters · filed 2026-03-23 | 118.88K shares 10-K · filed 2026-03-23 |
| 2024-09-30 | 14.01K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 14.01K shares derived: sum of 2 quarters · filed 2024-11-13 | 26.33K shares 10-Q · filed 2024-11-13 | 27.08K shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 12.32K shares 10-Q · filed 2024-08-14 | 13.07K shares derived: sum of 3 quarters · filed 2025-03-31 | 23.52K shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | 12.32K shares 10-Q · filed 2024-05-14 | 13.07K shares derived: sum of 2 quarters · filed 2025-03-31 | 23.52K shares derived: sum of 3 quarters · filed 2025-03-31 | 28.08K shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | 750.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 11.20K shares derived: sum of 2 quarters · filed 2025-03-31 | 15.76K shares derived: sum of 3 quarters · filed 2025-03-31 | 106.56K shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 10.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 15.01K shares derived: sum of 2 quarters · filed 2023-11-14 | 105.81K shares 10-Q · filed 2023-11-14 | 106.75K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 4.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 95.36K shares 10-Q · filed 2023-08-10 | 96.30K shares derived: sum of 3 quarters · filed 2023-08-10 | -647.50K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 90.80K shares 10-Q · filed 2023-05-10 | 91.75K shares derived: sum of 2 quarters · filed 2023-08-01 | -652.05K shares derived: sum of 3 quarters · filed 2023-08-01 | -357.26K shares derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-12-31 | 947.00 shares derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | -742.85K shares derived: sum of 2 quarters · filed 2023-08-01 | -448.06K shares derived: sum of 3 quarters · filed 2023-08-01 | 69.84K shares 8-K · filed 2023-08-01 |
| 2022-09-30 | -743.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -449.01K shares derived: sum of 2 quarters · filed 2022-11-14 | 68.89K shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 294.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 812.69K shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 517.90K shares 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | 801.75K shares 10-K · filed 2022-03-10 | |||
| 2020-12-31 | 1.04M shares 10-K · filed 2021-03-15 | |||
| 2019-12-31 | 277.41K shares 10-K · filed 2020-03-16 | |||
| 2018-12-31 | 232.91K shares 10-K · filed 2019-03-07 | |||
| 2017-12-31 | 351.92K shares 10-K · filed 2018-03-09 | |||
| 2016-12-31 | 67.53K shares 10-K · filed 2017-03-03 | |||
| 2015-12-31 | 372.72K shares 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |